Back to search
FDAFDA · Food and drugs·Recall number D-1332-2019

Sermorelin/GHRP-2 9 mg/6 mg vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846

Published June 19, 2019 · Recall initiated: May 23, 2019

Summary

FDA records drug Class II recall D-1332-2019, published June 19, 2019 and initiated May 23, 2019. Recalling firm: Pharm D Solutions, LLC; Status: Terminated; Reported quantity: 66 vials; Lot: Lot #: 03052019:43 Exp. 08/31/2019; 04042019:15 Exp. 10/01/2019; 04172019:08 Exp. 08/31/2019; 05022019:47 Exp. 10/30/2019; 05082019:78 Exp. 06/04/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Sterility Assurance.

What to do

FDA Mandated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharm D Solutions, LLC
Distributor
Nationwide within the United States
Lot
Lot #: 03052019:43 Exp. 08/31/2019; 04042019:15 Exp. 10/01/2019; 04172019:08 Exp. 08/31/2019; 05022019:47 Exp. 10/30/2019; 05082019:78 Exp. 06/04/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sermorelin/GHRP-2 9 mg/6 mg vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054, 1-844-263-6846 recalled?

Yes. FDA published recall D-1332-2019 on June 19, 2019. Reported hazard: Lack of Sterility Assurance.

What should I do if I have this product?

FDA Mandated · Press Release